Glycerin

Glycerin

SCHEMBL3681774

CC=CC=CCO.OCC(O)CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CNR2 P34972 4/20 0.31
CNR1 P21554 2/20 0.31
THRB P10828 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL27263058 1.00 LMNA (0.43) LMNAALDH1A1CNR2CNR1THRB
Glycerin SCHEMBL27541391 0.94 ALDH1A1 (0.38) LMNAALDH1A1
Glycerin SCHEMBL27823320 0.92 ALDH1A1 (0.36) LMNAALDH1A1CNR2CNR1PPARG
Glycerin SCHEMBL27706378 0.87 FFAR3 (0.36) LMNAALDH1A1CNR2CNR1PPARG
1,3-Butanediol SCHEMBL27356306 0.87 THRB (0.37) LMNAALDH1A1THRB
Propylene Glycol SCHEMBL27955451 0.86 TDP1 (0.48) CNR2CNR1PPARGPPARDPPARA
SCHEMBL20034059 0.84
SCHEMBL13892466 0.84
SCHEMBL734653 0.84
SCHEMBL21952 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403818-B1 CONVERSION OF SUGAR, SUGAR ALCOHOL, OR GLYCEROL TO VALUABLE CHEMICALS USING A PROMOTED ZIRCONIUM OXIDE SUPPORTED CATALYST CLARIANT CORP (US) 2020-07-15 EP claimed
EP-0143857-B1 THERAPEUTIC CORONARY COMPOSITION IN THE FORM OF SOFT GELATINE CAPSULES SIEGFRIED AKTIENGESELLSCHAFT (CH) 1988-04-06 EP claimed
EP-0143857-A1 Therapeutic coronary composition in the form of soft gelatine capsules SIEGFRIED AKTIENGESELLSCHAFT (CH) 1985-06-12 EP claimed
JP-1289441-A None JP disclosed
JP-3280003-A None JP disclosed
EP-1875905-B1 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances BAYER SCHERING PHARMA AG (DE) 2010-05-12 EP disclosed
EP-1617827-B1 PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES BAYER SCHERING PHARMA AG (DE) 2008-02-13 EP disclosed
EP-1875905-A2 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances Bayer Schering Pharma Aktiengesellschaft (DE) 2008-01-09 EP disclosed
EP-1617827-A1 PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES Schering Aktiengesellschaft (DE) 2006-01-25 EP disclosed
WO-2004096191-A1 PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES SCHERING AKTIENGESELLSCHAFT (DE) 2004-11-11 WO disclosed
EP-0885288-A1 BODY SOAP COMPOSITION Johnson & Johnson Kabushiki Kaisha (JP) 1998-12-23 EP disclosed
WO-1997027279-A1 BODY SOAP COMPOSITION JOHNSON & JOHNSON KABUSHIKI KAISHA (JP) 1997-07-31 WO disclosed
EP-0448813-B1 Stable dispersions of polyureas and/or polyhydrazodicarbonamides in high-molecular weight compounds containing at least one hydroxyl group, a process for their preparation and their use in the preparation of polyurethane plastics BAYER AG (DE) 1993-11-03 EP disclosed
JP-H03280003-A COMPOSITION FOR BUNDLING OPTICAL FIBER, METHOD FOR BUNDLING OPTICAL FIBER AND OPTICAL FIBER BUNDLE OBTAINED BY THIS METHOD FUJIKURA LTD 1991-12-11 JP disclosed
JP-H01289441-A MOUNTING PAPER FOR HEAT-FORMED STARCH FOOD OSAKA KAGAKU GOKIN KK 1989-11-21 JP disclosed
US-3992261-A BACILLI, BETA-AMYLASE, ALPHA-1,6-GLUCOSIDASE AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JA) 1976-11-16 US disclosed